Moderna, Inc.
MRNA
$25.18
$1.124.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 753.51% | 32.56% | |||
| Total Other Revenue | 53.57% | 27.27% | |||
| Total Revenue | 615.49% | 31.48% | |||
| Cost of Revenue | -65.69% | -13.42% | |||
| Gross Profit | 208.57% | 19.21% | |||
| SG&A Expenses | 16.52% | 8.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 21.64% | -9.41% | |||
| Operating Income | 71.33% | 13.62% | |||
| Income Before Tax | 77.14% | 15.15% | |||
| Income Tax Expenses | 85.71% | 0.00% | |||
| Earnings from Continuing Operations | 75.76% | 15.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 75.76% | 15.04% | |||
| EBIT | 71.33% | 13.62% | |||
| EBITDA | 75.53% | 15.92% | |||
| EPS Basic | 75.88% | 15.47% | |||
| Normalized Basic EPS | 76.77% | 14.96% | |||
| EPS Diluted | 75.88% | 15.47% | |||
| Normalized Diluted EPS | 76.77% | 14.96% | |||
| Average Basic Shares Outstanding | 0.52% | 0.52% | |||
| Average Diluted Shares Outstanding | 0.52% | 0.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||